Top

Published in:

01-03-2003

Editorial

Authors: P. D. Delmas, J. D. Ringe

Published in: Osteoporosis International | Special Issue 3/2003

Excerpt

Several agents now available have been shown to reduce the risk of fracture in postmenopausal women with osteoporosis. All drugs currently available act by decreasing the rate of bone turnover, which is increased in postmenopausal osteoporosis. …

Title: Editorial
Authors: P. D. Delmas
J. D. Ringe
Publication date: 01-03-2003
Publisher: Springer-Verlag
Published in: Osteoporosis International / Issue Special Issue 3/2003
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI: https://doi.org/10.1007/s00198-002-1346-3

At a glance: The STEP trials

Springer Medicine

Editorial

Excerpt

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Special Issue 3/2003

Bone strength and its determinants

The mineralization of bone tissue: a forgotten dimension in osteoporosis research

Assessment of prevalent and incident vertebral fractures in osteoporosis research

Reduced bone formation and increased bone resorption: rational targets for the treatment of osteoporosis

Strontium ranelate phase 2 dose-ranging studies: PREVOS and STRATOS studies

Optimizing bone metabolism in osteoporosis: insight into the pharmacologic profile of strontium ranelate